CareMetx and Syneos Health Form Strategic Partnership to Accelerate Specialty Medication Access
核心洞察
CareMetx (搜索) and Syneos Health announced a strategic partnership to deliver a next-generation access model that provides faster, seamless support to providers and manufacturers for specialty medications (搜索).
The collaboration integrates CareMetx (搜索)'s proprietary technology platform with Syneos Health's Field Reimbursement Management teams and AI-powered healthcare intelligence platform, Kinetic (搜索).
The partnership aims to proactively address access challenges, streamline activation processes, and reduce integration time and burden for biopharma companies.
CareMetx (搜索), a leading technology-enabled hub services company, has announced a strategic engagement with Syneos Health, a fully integrated biopharmaceutical solutions organization, to transform patient access to specialty medications (搜索). The partnership combines CareMetx's advanced proprietary technology with Syneos Health's comprehensive patient access and support solutions to create a next-generation access model designed to speed therapies to patients.
Technology Integration Powers Enhanced Access Solutions
The collaboration will equip Syneos Health's Field Reimbursement Management (FRM) and Patient Engagement teams with CareMetx (搜索)'s rich data and insights that extend beyond traditional hub enrollment resources. This includes provider solutions, non-dispensing pharmacy data, and access to the Access Partner Network. When integrated with Syneos Health's access expertise and AI-powered healthcare intelligence platform, Kinetic (搜索), teams will be positioned to proactively address access challenges, streamline activation processes, and reduce integration time and burden.
"Partnering with Syneos Health brings together two complementary strengths—our proprietary technology platform and their proven field expertise," said Jim Rowe, Chief Executive Officer of CareMetx (搜索). "Together, we can offer manufacturers a more connected access model that reduces barriers, accelerates time to therapy and improves the experience for both patients and providers."
Addressing Current Market Challenges
As biopharma companies scale healthcare delivery, this partnership addresses current access challenges while adapting to evolving therapies, payer demands, and the need for measurable impact. The collaboration redefines patient services through a smarter, modular access model and provides a unified, real-time view of performance across hub and support teams.
Paul Mignon, President, Deployment Solutions at Syneos Health, emphasized the urgency manufacturers face in therapy initiation. "With decades of experience building and deploying patient access programs, our teams understand the urgency manufacturers face to accelerate therapy initiation," said Mignon. "By powering our teams with CareMetx (搜索)'s advanced technology and robust data, we can connect patients with the treatment they need faster and more effectively."
Company Backgrounds
CareMetx (搜索) serves as a technology-enabled hub services platform facilitating patient access to specialty medications (搜索) for pharmaceutical, biotechnology, and device manufacturers. The company leverages digital eServices integrated in a cohesive platform to promote efficiency in the healthcare ecosystem and remove barriers for patients and providers. Headquartered in Bethesda, Maryland, CareMetx currently serves more than 80 brands.
Syneos Health operates as a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. The company translates clinical, medical affairs, and commercial insights into outcomes to address modern market realities, bringing together professionals with deep understanding of patient and physician behaviors and market dynamics.